A recombinant DNA and vaccinia virus prime-boost regimen induces potent long-term T-cell responses to HCV in BALB/c mice (Q42986804)

12 November 2017

A recombinant DNA and vaccinia virus prime-boost regimen induces potent long-term T-cell responses to HCV in BALB/c mice (English)

1 reference

12 November 2017

vaccinia virus

1 reference

3

Wenjie Tan

1 reference

12 November 2017

Yao Deng

1

1 reference

12 November 2017

Ke Zhang

2

1 reference

12 November 2017

Yue Wang

4

1 reference

12 November 2017

Hong Chen

5

1 reference

12 November 2017

Xiaobing Wu

6

1 reference

12 November 2017

Li Ruan

7

1 reference

12 November 2017

language of work or name

English

0 references

publication date

12 February 2009

1 reference

12 November 2017

1 reference

12 November 2017

27

1 reference

12 November 2017

15

1 reference

12 November 2017

2085-2088

1 reference

Hepatitis B virus precore protein augments genetic immunizations of the truncated hepatitis C virus core in BALB/c mice

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Flying under the radar: the immunobiology of hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Immunology of hepatitis B virus and hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Analysis of a successful immune response against hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Current progress of DNA vaccine studies in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Prime boost vaccination strategies: CD8 T cell numbers, protection, and Th1 bias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8(+) responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

A DNA vaccine containing inverted terminal repeats from adeno-associated virus increases immunity to HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Production and purification of recombinant adeno-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Development of a heterologous, multigenotype vaccine against hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Evaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine Vehicle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.003

Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19356609

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Construction and application of plasmids containing bidirectional promoters of vaccinia virus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19356609

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.02.003

1 reference

12 November 2017

0 references

1 reference